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Abstract
Cyclobutanes containing one oxygen atom in a molecule are called oxetane-containing compounds (OCC). More than 600
different OCC are found in nature; they are produced by microorganisms, and also found in marine invertebrates and algae.
The greatest number of them is found in plants belonging to the genus Taxus. Oxetanes are high-energy oxygen-containing non-
aromatic heterocycles that are of great interest as new potential pharmacophores with a significant spectrum of biological
activities. The biological activity of OCC that is produced by bacteria and Actinomycetes demonstrates antineoplastic, antiviral
(arbovirus), and antifungal activity with confidence an angiogenesis stimulator, respiratory analeptic, and antiallergic activity
dominate with confidence from 81 to 99%.
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Introduction
Cyclobutane-containing metabolites are widely distributed in
nature and reported in the scientific literature (Fan et al. 2016;
Dembi t sky 2008 , 2014 ; Serge iko e t a l . 2008) .
Heterocyclobutanes containing atoms of oxygen (oxetanes),
nitrogen (azetidines), or sulfur (thietanes) are also found in
nature, but to a much lesser extent (Kingston et al. 2002;
Brandi et al. 2008; Leśniak et al. 2008; Alcaide and
Almendros 2011; Abe 2008).
At present, high-energy oxygen-containing non-aromatic
heterocycles are of great interest as novel pharmacophores
with diverse biological activities, and such compounds in-
clude endoperoxides and oxetanes (Vil et al. 2017, 2018;
Terent’ev et al. 2011, 2014; Dembitsky et al. 2007; Davis
and Bull 2015). Currently, both natural and synthetic oxetanes
are attracting the attention of pharmacologists, physicians, and
chemists as important motives for discovering new drugs be-
cause of their interesting physicochemical properties of these
compounds (Carreira and Fessard 2014; Prablek 2013;
Wuitschik 2008; Wang et al. 2000).
If one looks at oxetanes from the point of view of chemical
communication between bacteria and/or fungal endophytes,
one can explain the limited presence of oxetane ring in various
classes of natural compounds, an including isoprenoid lipids
(Chagas and Pupo 2018; Savidov et al. 2018; Du Toit 2016;
Wongsuk et al. 2016; Dembitsky et al. 2011). Bacterial and
fungal quorum sensing is an interesting research direction in
the field of medical chemistry and pharmacology and involves
the discovery of the chemical language of information ex-
change between bacteria or/and fungi (Taga and Bassler
2003; Waters and Bassler 2005; Lentini et al. 2017; Smoum
et al. 2012; Dembitsky and Gloriozova 2017).
The synthesis of the OCC is widely described in the scien-
tific literature (Appendino 1995; Kingston et al. 2002;
Burkhard et al. 2010; Wuitschik et al. 2010; Bull et al.
2016). Methods for the synthesis of some natural OCC are
also described; however, there are practically no reviews
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devoted to natural oxetane-containing compounds (OCC)
(Wang et al. 2011; Appendino 1995). According to some au-
thors, the presence in molecule of the oxetane group gives it a
definite activity against many pathogens (Kingston et al.
2002). More than 600 different OCC are found in nature; they
are produced by microorganisms, and also found in marine
invertebrates and algae. The greatest number of them is found
in plants belonging to the genus Taxus (Wang et al. 2000,
2011; Kingston et al. 2002; Das and Rao 1996; Appendino
1995).
The biosynthesis of the oxetane ring in the taxol molecule
has been thoroughly studied and described in many reviews,
and different groups of scientists have made chemically based
mechanistic suggestions for the biosynthesis of oxetane-
containing taxol and its derivatives (Willenbring and Tantillo
2008; Walker and Croteau 1999; Croteau et al. 2006).
However, today, the question of the biosynthesis of the oxetane
ring remains open and is quite intensively discussed in the
scientific literature (Meng et al. 2018; Howat et al. 2014).
Pharmacologists are known to claim that the biological ac-
tivity of both natural and synthetic compounds is related to the
chemical structure (Barlow 1979). As shown by numerous
studies in recent years, the stereo-electronic effects of organic
molecules demonstrate a link between reactivity and biological
activity. In addition, stereo-electronic effects are like a bridge
between the structure and the reactivity of the molecules.
These effects have wide practical application in asymmetric
catalysis, photochemical processes, bioorganic chemistry, bio-
chemistry, inorganic and organometallic reactivity, and supra-
molecular chemistry (Alabugin 2016; Alabugin et al. 2015).
Currently, a number of computer programs are known that,
with a certain degree of probability (Sliwoski et al. 2014;
Leelananda and Lindert 2016; Kokh et al. 2018), estimate
the activity of drug-like organic compounds (Bezhentsev
et al. 2017; Lagunin et al. 2014). The PASS program contains
information about one million chemical compounds and more
than 9000 biological activities (Filimonov et al. 2014). The
algorithm for practical use of PASS has been described in
detail in several publications (Vil et al. 2018; Filimonov
et al. 2018, Dembitsky et al. 2018). We used this program to
help us determine the biological activity of the OCC presented
in this article. The biological activity of many of these com-
pounds has not been studied previously.
The mini review presented by us is the first successful
analysis of the description of the chemical structures of natural
OCC and their biological activity.
Oxetane-containing compounds produced
by microorganisms
The OCC are produced by both bacteria and various strains of
Actinomycetes, moreover mainly Streptomyces strain. β-
Lactone called papulinone ((1), structure shown in Fig. 1
and activity shown in Table 1) is weakly phytotoxic on apple
and bean leaves, has been isolated from a rod-shaped, Gram-
negative bacterium Pseudomonas syringae (Evidente et al.
1990). Bradyoxetin (2) is a unique chemical component that
participates in symbiotic regulation of genes. This metabolite
produces a symbiotic bacterium Bradyrhizobium japonicum
(Loh et al. 2002). The ethyl acetate extract of a marine bacteria
Bacillus sp. from sediments (Ieodo, South Korea) yielded 24-
membered antibacterial macrolactone called macrolactin I (3)
(Mojid Mondol et al. 2011).
Belactins A (4) as a serine carboxypeptidase inhibitor was
discovered in the fermentation broth of Saccharopolyspora
sp. MK19-42F6 (known as Streptomyces erythraeus)
(Murakami et al. 1995a, b). An inhibitor of serine carboxy-
peptidase called belactins B (5) was discovered in the fermen-
tation broth of Saccharopolyspora sp. MK19-42F6
(Murakami et al. 1995a, b).
Two antitumor peptide antibiotics, belactosin A (6) and C
(7), acting on cyclin/CDK mediated cell cycle regulation pro-
duced by soil Streptomyces sp. KYI 1780 from Kanagawa
prefecture, Japan (Asai et al. 2000). Ebelactone B (8) is a β-
lactone potent inhibitor of pancreatic lipase produced by
Streptomyces aburaviensis (Nonaka et al. 1995; Ostrowska
et al. 2005). The potent inhibitor of pancreatic lipase called
lipstatin (9) was obtained from the fermentation broth of
Streptomyces toxytricini (Weibel et al. 1987).
A series of pancreatic lipase inhibitors with an oxetane ring
called panclicins A, B, C, D, and E are produced by
Streptomyces sp. NR0619 (Mutoh et al. 1994). The structure
of one of them panclicin E (10) is shown in Fig. 1.
Antibacterial the β-lactone antibiotics called diffusomycin
(11) derived from Streptomyces albus (Grafe et al. 1988),
and the same compound called oxazolomycin (11) produced
by Streptomyces sp. KBFP-2025 (Otani et al. 2000). Tonew
and co-authors (1992) showed that diffusomycin
(oxazolomycin) demonstrated also the antiviral activity
(Tonew et al. 1992).
Four β-lactones, 4α-(3,5-dihydroxy hexyl)-3α-methyl-
2-oxetanone (12), 4α-(3-methyl-4-formyloxy-hexyl)-3α-
methyl-2-oxetanone (13), 4α-(3,5-dihydroxy-heptyl)-3α-
methy l -2-oxe tanone (14) , and 4α - (3 -methyl -4-
formyloxy-heptyl)-3α-methyl-2-oxetanone (15), were ob-
tained from the endophytic Streptomyces sp. T1B1 which
was identified from the old bast tissue of Taxus
yunnanens is (Yuan et a l . 2013) . Act inomycete
Streptomyces albolongus MG147-CF2 was isolated from
a soil sample collected in Shirane Mountain, Gunma
Prefecture, contains antibiotic valilactone (16). The isolat-
ed compound inhibited hog liver esterase and hog pancre-
as lipase with IC50 values of 29 and 0.14 ng/mL, respec-
tively. It can also inhibit fatty acid synthase with an IC50
value of 0.3 μM and demonstrates selective toxicity
2450 Appl Microbiol Biotechnol (2019) 103:2449–2467
Fig. 1 Oxetane-containing compounds derived from microorganisms
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Table 1 Biological activities oxetane-containing compounds produced by microorganisms
No. Predicted biological activities of oxetane-containing compounds (Pa)*
1 Antineoplastic (0.790); antiviral (arbovirus) (0.670); fibrinolytic (0.652); phobic disorders treatment (0.624); genital warts treatment (0.552)
Antieczematic (0.530); lipid metabolism regulator (0.502)
2 Phobic disorders treatment (0.709); antidiabetic (0.624); psychotropic (0.592); genital warts treatment (0.589); antidyskinetic (0.560)
Antiviral (picornavirus) (0.528); antiviral (arbovirus) (0.504)
3 Antineoplastic (0.906); antifungal (0.813); antibacterial (0.799); antiparasitic (0.770); immunosuppressant (0.757); cytostatic (0.702)
Antimetastatic (0.692); apoptosis agonist (0.679); antieczematic (0.671); genital warts treatment (0.671); respiratory analeptic (0.619)
4 Antihypertensive (0.972); general pump inhibitor (0.849); diuretic (0.630); antidyskinetic (0.618); antiviral (arbovirus) (0.601)
5 Antihypertensive (0.924); genital warts treatment (0.806); general pump inhibitor (0.797); antineoplastic (0.665); antihemorrhagic (0.595)
Antidiabetic (0.579); immunosuppressant (0.567)
6 Mucositis treatment (0.660); antieczematic (0.629); allergic conjunctivitis treatment (0.617); immunosuppressant (0.591); antineoplastic (0.578)
Antibiotic glycopeptide-like (0.572)
7 Mucositis treatment (0.890); antineoplastic (0.690); natural killer cell stimulant (0.673); antieczematic (0.646); psychostimulant (0.614)
Radioprotector (0.610); antiviral (arbovirus) (0.602); antifungal (0.568); neuroprotector (0.546); biliary tract disorders treatment (0.532)
8 Antineoplastic (0.932); antifungal (0.861); hypolipemic (0.829); antibacterial (0.796); antiparasitic (0.775); antieczematic (0.738)
Lipid metabolism regulator (0.737); immunosuppressant (0.731); apoptosis agonist (0.695); antihelmintic (0.681); antiinflammatory (0.579)
9 Antieczematic (0.879); antidiabetic symptomatic (0.779); antineoplastic (0.749); antifungal (0.706); antibacterial (0.674); antiinflammatory (0.638)
Immunosuppressant (0.634); hypolipemic (0.588); antithrombotic (0.574); apoptosis agonist (0.556); antileukemic (0.546); antiulcerative (0.534)
10 Antidiabetic symptomatic (0.807); antineoplastic (0.692); antieczematic (0.679); antifungal (0.634); antibacterial (0.591); hypolipemic (0.576)
Chemoprotective (0.573); antithrombotic (0.547); lipase inhibitor (0.529); antiulcerative (0.520)
11 Antineoplastic (0.926); alkylator (0.747); antibacterial (0.591); antineoplastic antibiotic (0.564); genital warts treatment (0.516)
12 Antieczematic (0.810); antineoplastic (0.739); lipid metabolism regulator (0.700); hypolipemic (0.698); antiinfective (0.692); antiparasitic (0.684)
Antiviral (arbovirus) (0.681); antifungal (0.673); antiischemic, cerebral (0.644); vasoprotector (0.626); antidiabetic (0.621); immunosuppressant
(0.617)
Antinephrotoxic (0.611); antihelmintic (0.604); antiinflammatory (0.582); antihypertensive (0.565); antipruritic, allergic (0.557)
13 Antieczematic (0.729); antihypertensive (0.716); antineoplastic (0.659); antibacterial (0.617); genital warts treatment (0.531)
Antiviral (arbovirus) (0.510); hypolipemic (0.507)
14 Antieczematic (0.829); hypolipemic (0.742); vasoprotector (0.719); antiviral (arbovirus) (0.719); lipid metabolism regulator (0.697)
Antifungal (0.681); antineoplastic (0.672); immunosuppressant (0.654); antinephrotoxic (0.631); kidney function stimulant (0.607)
Antiinflammatory (0.596); antiparasitic (0.588); antihypertensive (0.587); antidiabetic (0.577); antipruritic, allergic (0.573); leukopoiesis stimulant
(0.561)
15 General pump inhibitor (0.956); protein synthesis inhibitor (0.766); antieczematic (0.740); antibacterial (0.629); antineoplastic (0.595)
Antihypertensive (0.590); antiviral (arbovirus) (0.534); hypolipemic (0.524)
16 Antidiabetic symptomatic (0.792); antineoplastic (0.732); antifungal (0.664); antibacterial (0.639); antieczematic (0.619); immunosuppressant
(0.571)
Antileukemic (0.561); cytostatic (0.541); hypolipemic (0.538); antithrombotic (0.509)
17 Antibiotic glycopeptide-like (0.965); phobic disorders treatment (0.837); genital warts treatment (0.787); antiinflammatory (0.722)
Antiviral (arbovirus) (0.704); antiarthritic (0.689); antiviral (picornavirus) (0.667); antinephrotoxic (0.643); antibacterial (0.582); antieczematic
(0.580)
18 Antineoplastic (multiple myeloma) (0.981); apoptosis agonist (0.946); autoimmune disorders treatment (0.900); antineoplastic (0.894)
Proteasome inhibitor (0.855); rheumatoid arthritis treatment (0.846); angiogenesis inhibitor (0.838); antiasthmatic (0.796); antibacterial (0.685)
Antiarthritic (0.654); multiple sclerosis treatment (0.619); antiischemic, cerebral (0.591); antieczematic (0.589); radiosensitizer (0.509)
19 Antineoplastic (0.850); antiinflammatory (0.753); antileukemic (0.643); antibacterial (0.641); antieczematic (0.518)
20 Antipsoriatic (0.885); antineoplastic (0.828); apoptosis agonist (0.797); immunosuppressant (0.741); antieczematic (0.719); antiacne (0.678)
Antiinflammatory (0.678); chemopreventive (0.668); antifungal (0.624); respiratory analeptic (0.527); antileukemic (0.512); antiviral (HIV)
(0.505)
21 Antineoplastic (0.869); potassium channel blocker (0.827); chloride channel blocker (0.811); hypolipemic (0.799); antihypertensive (0.709)
Interleukin antagonist (0.676); apoptosis agonist (0.613); antiarthritic (0.551)
22 Genital warts treatment (0.930); angiogenesis inhibitor (0.918); antineoplastic (0.918); vasoprotector (0.861); antifungal (0.827); antiparasitic
(0.819)
Hepatoprotectant (0.789); antihypercholesterolemic (0.781); antihelmintic (0.780); antiinflammatory (0.769); neuroprotector (0.753); antibacterial
(0.744)
Antihypoxic (0.739); antidiabetic (0.721); antithrombotic (0.710); cytostatic (0.692); radioprotector (0.686); apoptosis agonist (0.675)
23 Antineoplastic (0.836); antifungal (0.762); antiinflammatory (0.752); chemopreventive (0.725); skin whitener (0.703); antiprotozoal (0.626)
Apoptosis agonist (0.617); antibacterial (0.613); cytostatic (0.562)
24 Antineoplastic (multiple myeloma) (0.990); apoptosis agonist (0.964); antineoplastic (0.947); autoimmune disorders treatment (0.937)
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toward MDA-MB-231 breast cancer cells with an IC50
value of 10 μM (Kitahara et al. 1987). (2R,3S)-3-
Amino-2-oxetane carboxylic acid called oxetin (17) was
isolated from a fermentation broth of a Streptomyces sp.
OM-2317 (Omura et al. 1984). Cinnabaramide A (18) as a
proteasome inhibitor was detected in fermentation broth
of Streptomyces sp. JS360 (Rachid et al. 2011). A marine-
derived Streptomyces sp. has led to the isolation of
ansalactam D (19) (Le et al. 2016).
Tricyclic sesquiterpene called cyclodehydroisolubimin (20)
has been isolated from potato tubers inoculated with an
oomycetePhytophthora infestans (Coxon et al. 1979). A fungal
indol-diterpenoid with oxetane ring called pennigritrem (21)
was isolated from Penicillium nigricans (Penn et al. 1992).
A phytotoxin, FCRR-Toxin (22), was isolated from the
culture filtrate of Fusarium oxysporum f. sp. radicis-
lycopersici (Hirota et al. 1994). Fungal β-lactone hymeglusin
(23, also known as antibiotic F 244) produced by Fusarium
sp. It inhibited HMG-CoA synthase (IC50 = 0.12 μM) by co-
valently modifying the active Cys129 residue of the enzyme
(Greenspan et al. 1987; Tomoda et al. 2004).
The marine Salinispora tropica produced antibiotics,
salinosporamide A (24), and omuralide (25) (Manam et al.
2009). Sesquiterpene called stereumone A (26) was isolated
from a culture broth of the fungus Stereum sp. (Li et al. 2006)
which showed nematicidal activity against nematode
Panagrellus redivivus.
A few natural products possessing vibralactone skeleton,
vibralactone B (27, structure shown in Fig. 2 and activity
shown in Table 2), vibralactone C (28), and acetylated
vibralactone (29) have been isolated from cultures of the ba-
sidiomycete Boreostereum vibrans (Jiang et al. 2008).
Vibralactone (30) has been isolated from cultures of
B. vibrans (Duan et al. 2018).
Highly oxygenated p-terphenyl, hawaiienol A (31), has
been isolated from cultures of Paraconiothyrium
hawaiiense, a fungus associated with the Septobasidium-
infected insect Diaspidiotus sp. The compound (31) with
4,7-dioxatricyclo[3.2.1.03,6]octane unit in its p-terphenyl
skeleton and showed cytotoxicity toward six human tumor
cell lines (Ren et al. 2018). Pentacyclic depsidone contain-
ing an oxetane unit, phomopsidone A (32), was isolated
Table 1 (continued)
No. Predicted biological activities of oxetane-containing compounds (Pa)*
Angiogenesis inhibitor (0.925); rheumatoid arthritis treatment (0.922); antiarthritic (0.718); antiasthmatic (0.697); antibacterial (0.684)
25 Autoimmune disorders treatment (0.995); antiischemic, cerebral (0.994); multiple sclerosis treatment (0.994); transplant rejection treatment (0.983)
Neuroprotector (0.955); antineoplastic (0.932); antiasthmatic (0.929); antiinflammatory (0.923); angiogenesis inhibitor (0.918)
Rheumatoid arthritis treatment (0.902); antipsoriatic (0.862); stroke treatment (0.843); antiviral (arbovirus) (0.584); cardiovascular analeptic
(0.572)
26 Antidyskinetic (0.780); antineoplastic (0.744); genital warts treatment (0.660); allergic conjunctivitis treatment (0.641); antieczematic (0.639)
Antiviral (arbovirus) (0.592); antinephrotoxic (0.579); dementia treatment (0.574); antiinflammatory (0.557); ovulation inhibitor (0.529)
27 Antineoplastic (0.871); apoptosis agonist (0.842); antiinflammatory (0.760); antiviral (arbovirus) (0.743); cardiovascular analeptic (0.734)
Antibacterial (0.654); antieczematic (0.625); hypolipemic (0.593); cytostatic (0.592); antimetastatic (0.587); immunosuppressant (0.586)
Antiviral (picornavirus) (0.573); antifungal (0.558); antileukemic (0.551); antiallergic (0.542); antiparasitic (0.537); antiulcerative (0.528)
28 Apoptosis agonist (0.949); antineoplastic (0.897); antiulcerative (0.737); cardiovascular analeptic (0.688); antibacterial (0.651); antiviral
(arbovirus) (0.649); immunosuppressant (0.640); antiinflammatory (0.622); respiratory analeptic (0.610); antiparasitic (0.601); antihelmintic
(0.597)
Antifungal (0.574); hypolipemic (0.567); antileukemic (0.555); cytostatic (0.541)
29 Apoptosis agonist (0.939); antineoplastic (0.877); antiinflammatory (0.783); antiulcerative (0.780); immunosuppressant (0.688); antiparasitic
(0.686)
Hypolipemic (0.661); antibacterial (0.652); antiviral (arbovirus) (0.651); antihelmintic (0.637); antifungal (0.619); antileukemic (0.609)
Cytostatic (0.608); antieczematic (0.589); neuroprotector (0.585); cardiovascular analeptic (0.583)
30 Antieczematic (0.844); antineoplastic (0.839); genital warts treatment (0.743); antiinflammatory (0.727); apoptosis agonist (0.720); antileukemic
(0.636)
Antiprotozoal (0.612); antinephrotoxic (0.591); antimitotic (0.548); antiviral (arbovirus) (0.541); immunosuppressant (0.505)
31 Antineoplastic (0.790); genital warts treatment (0.751); apoptosis agonist (0.748); antiinflammatory (0.736); antiischemic, cerebral (0.700)
Antiallergic (0.640); antiasthmatic (0.572); myasthenia gravis treatment (0.563); kidney function stimulant (0.540); antifungal (0.524)
32 Apoptosis agonist (0.937); antineoplastic (0.875); cardiovascular analeptic (0.781); antiulcerative (0.778); antiviral (Arbovirus) (0.749)
Antiinflammatory (0.749); antiparasitic (0.733); antihelmintic (0.730); immunosuppressant (0.671); cytostatic (0.670); antieczematic (0.669)
Hypolipemic (0.655); antibacterial (0.643); antileukemic (0.627); antifungal (0.615); antiviral (picornavirus) (0.602); neuroprotector (0.592)
33 Respiratory analeptic (0.997); cytostatic (0.985); antimitotic (0.981); anticarcinogenic (0.960); proliferative diseases treatment (0.946)
Vasodilator (0.940); antineoplastic (0.911); radiosensitizer (0.736); chemosensitizer (0.639); antileukemic (0.623); prostate cancer treatment
(0.610)
*Only activities with Pa > 0.5 are shown
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from themangrove endophytic fungus Phomopsis sp. A123.
The bioactivity assays showed that this compound pos-
sesses cytotoxic, antioxidant, and antifungal activities
(Zhang et al. 2014).
A taxol derivative named 7-epi-10-deacetyltaxol (33) was
detected in the culture of an endophytic fungus Pestalotiopsis
microspora which isolated from the bark of Taxodium
mucronatum (Subban et al. 2017).
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Fig. 2 Oxetane-containing compounds derived from microorganisms and marine sources
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Oxetane-containing compounds derived
from marine sources
Several secochamigranes called laureacetal B (34, structure
shown in Fig. 2 and activity shown in Table 2), C (35), and
E (36) were identified from Japanese red algae Laurencia
nipponica (Kurata et al. 1983; Ji and Wang 2014). The bromo
compound, laureatin (37), was also isolated from L. nipponica
(Irie et al. 1970). Diterpene with anticancer activity known as
prevezol B (38) was found in the red algae Laurencia rigida
(Machado et al. 2010). Diterpenoid sphaeroxetane (39) was
detected in the red alga Sphaerococcus coronopifolius collect-
ed in the North Adriatic Sea (De Rosa et al. 1988). The diter-
pene having the 2,7-dioxa-tricyclo[4.2.1.0]nonane ring
subunit called dictyoxetane (40) was isolated from the brown
alga Dictyota dichotoma collected from the Indian Ocean
(Pullaiah et al. 1985).
The organic extract of the Formosan soft coral Nephthea
erecta led to the isolation of sesquiterpene (41) (Cheng
et al. 2009). Diterpene isovalerate, spongiolactone (42),
was isolated from the Mediterranean sponge Spongionella
gracilis (Mayol et al. 1987). A South African marine
sponge Axinella sp. yielded a series of anticancers of
sodwanone triterpenoids, including sodwanone I (43) and
sodwanone W (44) (Dai et al. 2006). Unusual asbestinane
diterpene (45) has been isolated from octocoral Briareum
asbestinum collected off the coast of Tobago, West Indies
(Dookran et al. 1994).
Table 2 Biological activities oxetane-containing compounds produced by microorganisms
No. Predicted biological activities of oxetane-containing compounds (Pa)*
34 Antineoplastic (0.859); antiprotozoal (Plasmodium) (0.706); antieczematic (0.701); antiinflammatory (0.684); stroke treatment (0.673)
Immunosuppressant (0.671); apoptosis agonist (0.656); respiratory analeptic (0.648); antipsoriatic (0.644); antimitotic (0.586)
35 Antiprotozoal (Plasmodium) (0.875); antineoplastic (0.838); apoptosis agonist (0.787); respiratory analeptic (0.779); antiinflammatory (0.744)
Antieczematic (0.707); antipsoriatic (0.653); antimetastatic (0.647); immunosuppressant (0.640); antifungal (0.575)
36 Respiratory analeptic (0.875); antineoplastic (0.834); antiprotozoal (Plasmodium) (0.779); antiinflammatory (0.777); autoimmune disorders
treatment (0.742); apoptosis agonist (0.730); antipsoriatic (0.690); immunosuppressant (0.688); rheumatoid arthritis treatment (0.638);
antiparasitic (0.601)
Antieczematic (0.587); antifungal (0.548); antihelmintic (0.546); inflammatory bowel disease treatment (0.544); antiasthmatic (0.516)
37 Antiprotozoal (Plasmodium) (0.906); antineoplastic (0.843); apoptosis agonist (0.676); respiratory analeptic (0.632)
38 Apoptosis agonist (0.898); antineoplastic (0.742); antiprotozoal (Plasmodium) (0.629); antifungal (0.587); antibacterial (0.576)
Chemoprotective (0.568); antiemetic (0.549); antimetastatic (0.524)
39 Antineoplastic (0.874); apoptosis agonist (0.819); antieczematic (0.747); antiprotozoal (Plasmodium) (0.645); hypolipemic (0.635)
Antileukemic (0.633); antipsoriatic (0.626); postmenopausal disorders treatment (0.610); prostate cancer treatment (0.584); antimetastatic (0.559)
Antifungal (0.550); antiinflammatory (0.549)
40 Antineoplastic (0.960); angiogenesis inhibitor (0.891); antiinflammatory (0.799); immunosuppressant (0.741); autoimmune disorders treatment
(0.694)
Prostate cancer treatment (0.662); antimetastatic (0.614); antiarthritic (0.594); apoptosis agonist (0.584); antifungal (0.557); antipsoriatic (0.555)
Signal transduction pathways inhibitor (0.546); antieczematic (0.527); antiallergic (0.526)
41 Antineoplastic (0.960); angiogenesis inhibitor (0.891); antiinflammatory (0.799); immunosuppressant (0.741); autoimmune disorders treatment
(0.694)
Prostate cancer treatment (0.662); antimetastatic (0.614); antiarthritic (0.594); apoptosis agonist (0.584); antifungal (0.557); antipsoriatic (0.555)
Signal transduction pathways inhibitor (0.546); antieczematic (0.527); antiallergic (0.526)
42 Antineoplastic (0.789); genital warts treatment (0.772); antiinflammatory (0.733); immunosuppressant (0.682); antiinfertility, female (0.674)
Apoptosis agonist (0.657); antieczematic (0.634); antipruritic (0.613); prostate disorders treatment (0.581); neuroprotector (0.595)
Antiosteoporotic (0.548); hypolipemic (0.537)
43 Antineoplastic (0.793); antieczematic (0.684); immunosuppressant (0.623); antimitotic (0.578); antibacterial (0.567); antimetastatic (0.566)
Antineoplastic (renal cancer) (0.537)
44 Antineoplastic (0.812); antiviral (0.626); antibacterial (0.599); immunosuppressant (0.579); genital warts treatment (0.558); antimetastatic (0.525)
45 Antineoplastic (0.904); angiogenesis inhibitor (0.822); antimitotic (0.762); antimetastatic (0.691); antiprotozoal (Plasmodium) (0.690)
Antifungal (0.687); antibacterial (0.686); immunosuppressant (0.625); antileukemic (0.604); cytostatic (0.548); antiparasitic (0.541)
Apoptosis agonist (0.516); antinephrotoxic (0.513); Alzheimer’s disease treatment (0.501)
46 Respiratory analeptic (0.845); antihypercholesterolemic (0.828); biliary tract disorders treatment (0.827); antieczematic (0.824); antineoplastic
(0.815)
Hypolipemic (0.810); antipruritic (0.787); antifungal (0.743); hepatoprotectant (0.729); immunosuppressant (0.726); antiinflammatory (0.717)
Antipsoriatic (0.651); prostate disorders treatment (0.649); antiosteoporotic (0.623); antiprotozoal (Plasmodium) (0.621); antibacterial (0.620)
Cholesterol synthesis inhibitor (0.612); atherosclerosis treatment (0.602); dementia treatment (0.569)
*Only activities with Pa > 0.5 are shown
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Fig. 3 Oxetane-containing compounds derived from fungi and plants
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Table 3 Biological activities oxetane-containing compounds derived from fungi and plants
No. Predicted biological activities of oxetane-containing compounds (Pa)*
47 Angiogenesis stimulant (0.993); apoptosis agonist (0.967); antineoplastic (0.909); antieczematic (0.811); antifungal (0.732); antiparasitic (0.702)
Antihelmintic (0.681); lipid metabolism regulator (0.676); antiviral (arbovirus) (0.632); antibacterial (0.631); spasmolytic, urinary (0.629)
Vasoprotector (0.621); immunosuppressant (0.620); antipruritic (0.589); cardiovascular analeptic (0.588); mucositis treatment (0.551)
Antiulcerative (0.545); antipsoriatic (0.544); platelet aggregation inhibitor (0.538)
48 Antiarthritic (0.959); antiallergic (0.942); apoptosis agonist (0.822); antiinflammatory (0.766); antiviral (arbovirus) (0.732); hypolipemic (0.725)
Antineoplastic (0.712); cell adhesion molecule inhibitor (0.706); thrombolytic (0.704); antieczematic (0.700); cardiovascular analeptic (0.685)
Antioxidant (0.656); antiulcerative (0.613); antifungal (0.607); antithrombotic (0.606); spasmolytic (0.565)
49 Antieczematic (0.834); antiparasitic (0.774); phobic disorders treatment (0.767); hypolipemic (0.743); antifungal (0.715); antihelmintic (0.695)
Antiinflammatory (0.684); antineoplastic (0.660); Alzheimer’s disease treatment (0.657); antiarthritic (0.652); immunosuppressant (0.651)
Lipid metabolism regulator (0.628); antinephrotoxic (0.605); antibacterial (0.596); angiogenesis stimulant (0.593)
50 Respiratory analeptic (0.836); antineoplastic (0.789); apoptosis agonist (0.764); skin whitener (0.746); antiparasitic (0.735); neuroprotector (0.642)
Spasmolytic (0.633); antiinflammatory (0.626); immunosuppressant (0.623); antibacterial (0.609); cytostatic (0.602); antifungal (0.601)
Hepatoprotectant (0.586); antiischemic, cerebral (0.583); antihelmintic (0.574); antioxidant (0.564)
51 Antineoplastic (0.841); respiratory analeptic (0.813); chemopreventive (0.772); immunosuppressant (0.772); antifungal (0.755)
Apoptosis agonist (0.726); hepatoprotectant (0.700); antibacterial (0.662); antimitotic (0.627); hypolipemic (0.592); cytostatic (0.574)
52 Antineoplastic (0.795); immunosuppressant (0.767); apoptosis agonist (0.766); respiratory analeptic (0.721); chemopreventive (0.715)
Antiinflammatory (0.657); hepatoprotectant (0.653); antifungal (0.622); cardiotonic (0.608); antibacterial (0.546); prostate disorders treatment
(0.517)
53 Genital warts treatment (0.930); angiogenesis inhibitor (0.918); antineoplastic (0.918); vasoprotector (0.861); antifungal (0.827); antiparasitic
(0.819)
Hepatoprotectant (0.789); antihypercholesterolemic (0.781); antihelmintic (0.780); antiinflammatory (0.769); neuroprotector (0.753); antibacterial
(0.744)
Antihypoxic (0.739); antidiabetic (0.721); antithrombotic (0.710); cytostatic (0.692); radioprotector (0.686); apoptosis agonist (0.675)
54 Genital warts treatment (0.803); antineoplastic (0.718); apoptosis agonist (0.681); antimitotic (0.564); fibrinolytic (0.562); chemopreventive
(0.560)
Antiinflammatory (0.535); preneoplastic conditions treatment (0.530); mucositis treatment (0.519); antifungal (0.506)
55 Genital warts treatment (0.807); antihypercholesterolemic (0.801); neuroprotector (0.684); antineoplastic (0.678); antieczematic (0.675)
Fibrinolytic (0.652); apoptosis agonist (0.618); antimutagenic (0.602); antiasthmatic (0.587); antiinflammatory (0.568)
Preneoplastic conditions treatment (0.567); hepatoprotectant (0.560); acute neurologic disorders treatment (0.538); vasodilator, coronary (0.534)
Antipyretic (0.527); antiallergic (0.519)
56 Antineoplastic (0.738); chemopreventive (0.731); antiinflammatory (0.716); antiarthritic (0.663); antieczematic (0.663); hepatic disorders
treatment (0.634); immunosuppressant (0.630); antidiabetic (0.626); apoptosis agonist (0.611); antiviral (influenza) (0.608); antinephrotoxic
(0.604)
Acute neurologic disorders treatment (0.593); antipruritic (0.533); antipsoriatic (0.524); hypolipemic (0.514); dementia treatment (0.505)
57 Antineoplastic (0.813); apoptosis agonist (0.760); chemopreventive (0.565); respiratory analeptic (0.533); ovulation inhibitor (0.510)
Prostate disorders treatment (0.501)
58 Antineoplastic (0.931); antieczematic (0.914); apoptosis agonist (0.894); antifungal (0.775); antiinflammatory (0.748); antipsoriatic (0.735)
Immunosuppressant (0.730); antibacterial (0.682); genital warts treatment (0.600); antileukemic (0.563); chemopreventive (0.550); spasmolytic
(0.541)
Cytostatic (0.530); antiosteoporotic (0.521)
59 Antieczematic (0.919); antineoplastic (0.916); apoptosis agonist (0.840); antiinflammatory (0.820); immunosuppressant (0.747); antipsoriatic
(0.738)
Antifungal (0.694); antibacterial (0.653); analeptic (0.652); antimetastatic (0.646); Alzheimer’s disease treatment (0.598); antiulcerative (0.578)
Antiosteoporotic (0.574); cytostatic (0.561); antileukemic (0.559)
60 Expectorant (0.884); genital warts treatment (0.854); antineoplastic (0.849); antitussive (0.766); antidyskinetic (0.707); apoptosis agonist (0.665)
Antineoplastic (myeloid leukemia) (0.580); spasmolytic (0.517); cardiovascular analeptic (0.515); antiinflammatory (0.513)
61 Wound healing agent (0.940); apoptosis agonist (0.871); hepatoprotectant (0.829); diuretic (0.810); antipruritic (0.789); antineoplastic (0.789)
Antiinflammatory (0.784); antiulcerative (0.783); lipid metabolism regulator (0.746); vasodilator, peripheral (0.729); antiviral (influenza) (0.695)
Immunosuppressant (0.682); prostate disorders treatment (0.649); antipsoriatic (0.620); antieczematic (0.619); antifungal (0.616)
Atherosclerosis treatment (0.512)
62 Antineoplastic (0.950); apoptosis agonist (0.909); cytostatic (0.871); antiinflammatory (0.848); antieczematic (0.842); antimitotic (0.811)
Antifungal (0.701); antiparasitic (0.691); antibacterial (0.667); antileukemic (0.653); spasmolytic (0.561); hepatoprotectant (0.531)
63 Antineoplastic (0.949); apoptosis agonist (0.942); antineoplastic (myeloid leukemia) (0.842); antieczematic (0.825); antiinflammatory (0.776)
Antiparasitic (0.769); antifungal (0.750); antibacterial (0.687); antileukemic (0.656); hepatoprotectant (0.569); antihelmintic (0.529)
64 Antineoplastic (0.950); apoptosis agonist (0.909); antineoplastic (myeloid leukemia) (0.874); cytostatic (0.871); antiinflammatory (0.848)
Antieczematic (0.842); antimitotic (0.811); antifungal (0.701); antiparasitic (0.691); antibacterial (0.667); antileukemic (0.653)
Genital warts treatment (0.595); spasmolytic (0.561); hepatoprotectant (0.531)
Appl Microbiol Biotechnol (2019) 103:2449–2467 2457
24,26-Epoxy-5β-cholestane-3α,7α,12α-triol known as
anhydrochimerol (46) was obtained from hydrolysis of bile
salts of the rabbit fish Chimaera monstrosa (Okada et al.
1962).
Oxetane-containing compounds derived
from fungi, plants, and insects
Butenolide, ramariolide B (47, structure shown in Fig. 3 and
activity shown in Table 3), has been isolated from the fruiting
bodies of the coral mushroom Ramaria cystidiophora (Centko
et al. 2012).
Acetone extract of the Indian herb Acalypha indica leaves
from the southern part of India particularly in Tamilnadu con-
tains the compound with oxitane ring (48) (Selvamani and
Balamurugan 2015). A β-lactone, vittatalactone (49), was iso-
lated from collections of airborne volatile compounds from
feeding male striped cucumber beetles, Acalymma vittatum
(Morris et al. 2005).
Artocarpol F (50) is a phenolic compound containing an
oxepine ring was isolated from the root bark of Artocarpus
rigida (Ko et al. 2001). Two ring A-secolimonoids,
aphanalide C (51) and limonoid with an unusual oxetane ring
between C-7 and C-14 called aphanalide J (52), were isolated
from the fruits of Aphanamixis polystachya (Wang et al.
2012). The aerial parts of Aruncus dioicus var. kamtschaticus
afforded monoterpenoid-O-β-D-glucopyranoside called
aruncide C (53) (Jeong et al. 2011). Two oxetane-containing
neolignans, called pahangine A (54) and B (55), were found in
extract of the barks of Beilschmiedia glabra (Nadia et al.
2018).
Methanol-chloroform extract of the roots of Ceriops
decandra collected from Kauvery estuary resulted in the iso-
lation of diterpenoid, ceriopsin F (56) (Anjaneyulu and Rao
2003), and 17-hydroxy-16-oxobeyer-9(11)-en-19-al (57) was
found in the stems of Bruguiera sexangula var. rhynchopetala
(Bao et al. 2005). Clementein (58), a guaianolide isolated from
Centaurea clementei (Massanet et al. 1983). An oxetane lac-
tone subexpinnatin C (59) is a secondary metabolite was iso-
lated from Centaurea canarienses (Collado et al. 1987). The
Table 3 (continued)
No. Predicted biological activities of oxetane-containing compounds (Pa)*
65 Antineoplastic (0.854); chemopreventive (0.767); neuroprotector (0.740); skin whitener (0.737); anticarcinogenic (0.727); hepatic disorders
treatment (0.709); vasodilator (0.702); antiobesity (0.697); apoptosis agonist (0.668); antioxidant (0.661); antifungal (0.617); spasmolytic,
urinary (0.611)
Antiulcerative (0.609); immunosuppressant (0.567); antileukemic (0.563); cytostatic (0.552)
66 Antineoplastic (0.869); cardiotonic (0.856); antiseborrheic (0.830); antihypertensive (0.774); spasmolytic, urinary (0.744); leukopoiesis inhibitor
(0.738); neuroprotector (0.735); antiviral (arbovirus) (0.734); respiratory analeptic (0.734); antinephrotoxic (0.727); antiinflammatory (0.725);
antiarrhythmic (0.699); antianginal (0.697); apoptosis agonist (0.692); antiviral (picornavirus) (0.661); vasoprotector (0.654); fibrinolytic
(0.651); antihypoxic (0.639); immunosuppressant (0.637); antiparasitic (0.627); hypolipemic (0.620); antifungal (0.603)
67 Genital warts treatment (0.726); vasoprotector (0.725); antineoplastic (0.706); antieczematic (0.684); antiseborrheic (0.682); cardiotonic (0.638);
antiviral (arbovirus) (0.632); respiratory analeptic (0.629); spasmolytic, urinary (0.627); antinephrotoxic (0.608); kidney function stimulant
(0.605); dementia treatment (0.588); erythropoiesis stimulant (0.586); antibacterial (0.578); alopecia treatment (0.562); antipruritic (0.551);
ovulation inhibitor (0.547)
68 Antineoplastic (0.699); apoptosis agonist (0.647); histidine kinase inhibitor (0.595); antieczematic (0.575); antipsoriatic (0.567)
69 Genital warts treatment (0.782); antineoplastic (0.737); immunosuppressant (0.728); Alzheimer’s disease treatment (0.684); antinephrotoxic
(0.639)
Antiinflammatory (0.632); antileukemic (0.558); antioxidant (0.538); apoptosis agonist (0.533)
70 Genital warts treatment (0.782); antineoplastic (0.765); Alzheimer’s disease treatment (0.712); antiinflammatory (0.706); antieczematic (0.679)
Immunosuppressant (0.674); antinephrotoxic (0.645); antileukemic (0.590); apoptosis agonist (0.553); cytostatic (0.546)
Neurodegenerative diseases treatment (0.540); antioxidant (0.530); antibacterial (0.529)
71 Stroke treatment (0.996); cognition disorders treatment (0.995); apoptosis agonist (0.908); antineoplastic (0.829); genital warts treatment (0.802)
Antimetastatic (0.612); antimitotic (0.535)
72 Genital warts treatment (0.731); general pump inhibitor (0.549); membrane integrity agonist (0.539); antineoplastic (0.534); cytoprotectant (0.518)
73 Antineoplastic (0.958); apoptosis agonist (0.902); antiinflammatory (0.811); antieczematic (0.787); antimitotic (0.727); antiprotozoal (0.717)
Antiarthritic (0.639); antipsoriatic (0.615); respiratory analeptic (0.612); immunosuppressant (0.610); antipruritic (0.550); antimetastatic (0.548)
Autoimmune disorders treatment (0.536); antibacterial (0.534)
74 Antineoplastic (0.931); apoptosis agonist (0.919); cytostatic (0.912); antiinflammatory (0.837); antieczematic (0.830); antiparasitic (0.739)
Antifungal (0.718); antileukemic (0.681); antibacterial (0.650); hepatoprotectant (0.638); hemostatic (0.611); spasmolytic (0.530)
75 Antineoplastic (0.935); apoptosis agonist (0.933); cytostatic (0.916); antieczematic (0.912); antiinflammatory (0.819); antiparasitic (0.779)
Antifungal (0.669); antibacterial (0.660); antileukemic (0.631); immunosuppressant (0.626); antihelmintic (0.588); hepatoprotectant (0.572)
*Only activities with Pa > 0.5 are shown
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Fig. 4 Oxetane-containing compounds derived from plants
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Table 4 Biological activities oxetane-containing compounds derived from plants
No. Predicted biological activities of oxetane-containing compounds (Pa)*
76 Antineoplastic (0.818); antidyskinetic (0.790); cardiovascular analeptic (0.685); analgesic (0.663); antieczematic (0.660); antinephrotoxic (0.604)
Immunosuppressant (0.540); kidney function stimulant (0.539); antifungal (0.510)
77 Cardiovascular analeptic (0.845); antineoplastic (0.801); hypolipemic (0.781); antiinflammatory (0.752); antiprotozoal (0.674); antifungal (0.663)
Antiseborrheic (0.653); antieczematic (0.644); antinephrotoxic (0.620); antiviral (arbovirus) (0.615); ovulation inhibitor (0.586)
Autoimmune disorders treatment (0.585); antipruritic, allergic (0.576); antiviral (picornavirus) (0.566); menopausal disorders treatment (0.542)
78 Renin release stimulant (0.885); antineoplastic (0.760); bilirubin oxidase inhibitor (0.693); phosphatase inhibitor (0.641); analgesic (0.619)
Calcium regulator (0.554)
79 Genital warts treatment (0.721); cytoprotectant (0.680); apoptosis agonist (0.627); antineoplastic (0.627); free radical scavenger (0.577)
Chemopreventive (0.567)
80 Apoptosis agonist (0.862); antineoplastic (0.841); respiratory analeptic (0.823); antiinflammatory (0.804); hepatic disorders treatment (0.735)
Antiarthritic (0.663); lipid metabolism regulator (0.618); antieczematic (0.617); diuretic (0.603); prostate disorders treatment (0.591)
Antidiabetic (0.587); immunosuppressant (0.575); antipruritic (0.561); antipsoriatic (0.555); antiulcerative (0.549); antiviral (influenza) (0.500)
81 Antineoplastic enhancer (0.982); antineoplastic (0.902); renin release stimulant (0.843); neurotrophic factor (0.751); antieczematic (0.507)
82 Antieczematic (0.772); antineoplastic (0.709); antinephrotoxic (0.668); immunosuppressant (0.656); antiinflammatory (0.644); antiallergic (0.632)
Antiasthmatic (0.597); antifungal (0.589); antiviral (arbovirus) (0.582); antiviral (picornavirus) (0.576); antipruritic, allergic (0.566)
Antiprotozoal (Plasmodium) (0.547); antipsoriatic (0.540); antiseborrheic (0.537); lipid metabolism regulator (0.531); antibacterial (0.524)
83 Apoptosis agonist (0.895); antineoplastic (0.872); hypolipemic (0.774); antiinflammatory (0.758); antieczematic (0.707)
Immunosuppressant (0.673); hepatic disorders treatment (0.639); prostate cancer treatment (0.570); antifungal (0.557); antiosteoporotic (0.547)
Dementia treatment (0.541); contraceptive (0.539); antileukemic (0.514)
84 Antineoplastic (0.892); antiinflammatory (0.838); immunosuppressant (0.804); antipruritic (0.790); apoptosis agonist (0.746)
Antihypercholesterolemic (0.725); antiallergic (0.684); lipid metabolism regulator (0.651); neuroprotector (0.633); prostate disorders treatment
(0.618)
Menopausal disorders treatment (0.617); hypolipemic (0.609); ovulation inhibitor (0.603); respiratory analeptic (0.602); hepatoprotectant (0.601)
Antifungal (0.598); antiprotozoal (0.597); antipsoriatic (0.583); antiosteoporotic (0.565); autoimmune disorders treatment (0.562)
85 Antineoplastic (0.908); antiinflammatory (0.845); analgesic (0.783); antieczematic (0.712); diuretic (0.644); antiseborrheic (0.521)
86 Antineoplastic (0.807); analgesic (0.783); cardiovascular analeptic (0.758); antitussive (0.689); antidyskinetic (0.624); antieczematic (0.612)
Antinephrotoxic (0.568); antibacterial (0.539); antileukemic (0.520)
87 Respiratory analeptic (0.893); antineoplastic (0.885); antimitotic (0.861); cytostatic (0.858); genital warts treatment (0.736)
Proliferative diseases treatment (0.642); chemopreventive (0.641); antiinflammatory (0.615); anticarcinogenic (0.610); antifungal (0.594)
Antileukemic (0.566); radiosensitizer (0.561); apoptosis agonist (0.546)
88 Respiratory analeptic (0.973); antineoplastic (0.899); antimitotic (0.866); cytostatic (0.840); antieczematic (0.765); antiinflammatory (0.759)
Anticarcinogenic (0.755); immunosuppressant (0.748); genital warts treatment (0.718); proliferative diseases treatment (0.700); antipsoriatic
(0.640)
Analgesic (0.608); radiosensitizer (0.603); antileukemic (0.579); antifungal (0.571)
89 Respiratory analeptic (0.997); anticarcinogenic (0.980); proliferative diseases treatment (0.971); cytostatic (0.957); antimitotic (0.949)
Vasodilator (0.921); antineoplastic (0.908); antieczematic (0.763); radiosensitizer (0.728); cancer associated disorders treatment (0.704)
Chemosensitizer (0.638); antileukemic (0.611); antiprotozoal (Leishmania) (0.610); prostate cancer treatment (0.574)
90 Respiratory analeptic (0.966); antineoplastic (0.911); antimitotic (0.897); cytostatic (0.864); anticarcinogenic (0.677); radiosensitizer (0.675)
Proliferative diseases treatment (0.645); prostate cancer treatment (0.632); antifungal (0.616); antileukemic (0.603); vasodilator (0.601)
Chemosensitizer (0.588); T cell inhibitor (0.587); antiinflammatory (0.565); antinephrotoxic (0.537)
91 Respiratory analeptic (0.975); antimitotic (0.871); antineoplastic (0.858); cytostatic (0.840); anticarcinogenic (0.702); antihypertensive (0.669)
Proliferative diseases treatment (0.652); radiosensitizer (0.649); antileukemic (0.611); vasodilator (0.607); cancer associated disorders treatment
(0.533)
92 Respiratory analeptic (0.972); antineoplastic (0.864); antimitotic (0.862); antieczematic (0.781); cytostatic (0.722); antihypertensive (0.671)
Anticarcinogenic (0.660); proliferative diseases treatment (0.635); radiosensitizer (0.622); antileukemic (0.616); antipsoriatic (0.599)
93 Respiratory analeptic (0.982); antineoplastic (0.922); antimitotic (0.873); antieczematic (0.773); cytostatic (0.727); anticarcinogenic (0.698)
Proliferative diseases treatment (0.690); immunosuppressant (0.629); antiinflammatory (0.622); radiosensitizer (0.616); antipsoriatic (0.600)
94 Respiratory analeptic (0.997); cytostatic (0.953); anticarcinogenic (0.950); proliferative diseases treatment (0.947); antineoplastic (0.934)
Vasodilator (0.915); antieczematic (0.779); radiosensitizer (0.740); chemosensitizer (0.676); prostate cancer treatment (0.665); antileukemic
(0.646)
Antipsoriatic (0.639); antineoplastic enhancer (0.612); rheumatoid arthritis treatment (0.520)
95 Antineoplastic (0.861); apoptosis agonist (0.821); genital warts treatment (0.738); antiinflammatory (0.720); immunosuppressant (0.677)
Chemopreventive (0.641); antioxidant (0.554); Alzheimer’s disease treatment (0.554); neurodegenerative diseases treatment (0.521)
96 Antineoplastic (0.866); antiinflammatory (0.778); genital warts treatment (0.707); apoptosis agonist (0.703); antifungal (0.642)
Antibacterial (0.633); immunosuppressant (0.568); antipruritic (0.557); chemopreventive (0.508)
*Only activities with Pa > 0.5 are shown
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plant growing in Australia Crotalaria virgulata subsp.
grantiana contains alkaloid grantaline (60) (Smith et al.
1984). Cyclocaric acid A (61) was detected in the ethanol
extract of Cyclocarya paliurus (Wright et al. 2014).
The South American flowering plant Disynaphia
halimifolia afforded sesquiterpene lactones, disyhamifolide
(62) and disynaphiolide (63) (Bohlmann et al. 1981a, b), and
flowers and leaves of Disynaphia multicrenulata from
Argentina contained sesquiterpene dilactone (64) (De
Gutierrez et al. 2001).
Flavonoid called derriflavanone (65) was discovered from
Chinese lianas Derris laxiflora. The stem bark of Duguetia
glabriuscula collected in the municipality of Jardim, Brazil,
contains two oxetane-containing metabolites, (66) and (+)-α-
santalan-9,11-epoxy-10-ol (67) (Gomes Pereira et al. 2003).
The aerial parts of Ethulia conyzoides from Egypt afforded
monoterpene 5-methyl -coumar in , ca l led 5 ′ -ep i -
isoethuliacoumarin B (68) (Mahmoud et al. 1998). Toxic me-
tabolites, neoanisatin (69) and anisatin (70), were isolated
from Japanese star anise Illicium anisatum (Yamada et al.
1968). A unique sesquiterpene bearing two γ-lactones and
an oxetane ring called merrilactone A (71) was isolated from
the pericarps of Illicium merrillianum, shows an intriguing
neurotrophic activity in the cultures of fetal rat cortical
neurons (Huang et al. 2000). Neolignan (72) was detected in
the aerial parts of Isodon coetsa (Zhao et al. 2011).
Unusual metabolite called maoyecrystal I (structure shown
in Fig. 3 and activity shown in Table 3, 73) with a 11,20:1,20-
diepoxy-ent-kaurane skeleton showed cytotoxic activity
against K562 cells was found in the extract of Isodan
japonicus (Han et al. 2004). The author believes that the pres-
ence of the oxetane group in the molecule maoyecrystal I
determines its biological activity.
Guaiagrazielolide (74), a guaianolide with a β-lactone ring
and an oxetane ring, has been obtained from leaves of the
South American flowering plant Grazielia sp. (Bohlmann
et al. 1981a, b) as well as the compound called 8-
hydroxygrazielolide (75). cis-Himachalane-type sesquiter-
penes, 2α,6α-epoxy-3-himachalene (76, structures shown in
Fig. 4 and activity shown in Table 4) and 2α,6α-
epoxyhimachalan-3β-ol (77), were isolated from the heart-
wood of Juniperus chinensis var. tsukusiensis (Shiu et al.
1999).
Limonoid, kigelianolide (78), was isolated from the ethyl
acetate-soluble fraction of the methanolic extract of an African
plant Kigelia africana. The obtained compound showed weak
inhibitory activities against the enzymes acetylcholinesterase,
butyrylcholinesterase, and lipoxygenase (Jabeen et al. 2013).
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Phenolic amide, lyciumamide C (79), was identified from
the stem of Lycium barbarum, and exhibited moderate anti-
cancer activity against human glioma stem cell lines (Gao
et al. 2015; Zhu et al. 2017).
Norfriedelane A possessing anα-oxo-β-lactone group (80)
and showed acetylcholinesterase inhibitory effects with the
IC50 value of 10.3 μM was isolated from the branches and
roots of Malpighia emarginata (Liu et al. 2013). ent-
Trachylobane diterpenoid, mitrephorone A (81), possesses a
hexacyclic ring system with adjacent ketone moieties and an
oxetane ring was detected in the stem bark of Mitrephora
glabra (Li et al. 2005).
Parthoxetin (82) was detected in a flowering plant
Parthenium fruticosum (Chrysanthemum family).
Triterpenoid carbon framework, named petatrichol B (83),
was isolated from the rhizome of Petasites tricholobus. The
isolated compound exhibited significant antibacterial activity
against Bacillus subtilis (Xie et al. 2005). A series of
ergostane-type steroids, including petuniasterone P1 (84),
were isolated from leaves and stems of Petunia hybrida
(Elliger et al. 1988, 1989). Limonoid, 7,14-epoxy-azedarachin
B (85), was detected in a methanol extract of the roots of
Melia azedarach (Fukuyama et al. 2006). An alkaloid 1,9-
epoxy-9α-hydroxystenine (86) has been isolated from the
roots of Stemona tuberosa (Uyeo et al. 1967).
The genus Taxus contains more than 450 taxane diterpenes,
including tasumatrols A-W many of which contained oxetane
ring (Shen et al. 2005). Thus, an acetone extract of the leaves
and twigs of Taxus sumatrana has resulted in the isolation of
bicyclic taxoid tasumatrol Y (87) and tasumatrol V (88) (Shen
et al. 2008). Anticancer agent taxoprexin (89) was first isolat-
ed from the bark of Taxus brevifolia (Wani et al. 1971; Jones
et al. 2008). Taxane diterpene taxagifine III (90) was isolated
from the leaves and stems of Taxus chinensis (Zhang and Jia
Table 5 Biological activities
oxetane-containing compounds
derived from plants
No. Predicted biological activities of oxetane-containing compounds (Pa)*
97 Antineoplastic (0.913); antieczematic (0.604); apoptosis agonist (0.586); hepatic disorders treatment
(0.565); antileukemic (0.554)
Antiinflammatory (0.517); antimitotic (0.513); antimetastatic (0.501)
98 Antineoplastic (0.824); hepatic disorders treatment (0.576); apoptosis agonist (0.558); antineoplastic
(genitourinary cancer) (0.552)
Antidiabetic symptomatic (0.542)
99 Antineoplastic (0.829); apoptosis agonist (0.652); antieczematic (0.634); immunosuppressant (0.585);
antineoplastic (genitourinary cancer) (0.533)
100 Apoptosis agonist (0.916); antineoplastic (0.895); antiinflammatory (0.843); immunosuppressant (0.801);
antileukemic (0.754); cardiotonic (0.708)
Autoimmune disorders treatment (0.623); respiratory analeptic (0.610); hepatoprotectant (0.595);
antieczematic (0.578); antiarthritic (0.573)
Cytostatic (0.568); antifungal (0.564); antinephrotoxic (0.550); dementia treatment (0.525)
102 Antineoplastic (0.863); antiinflammatory (0.731); genital warts treatment (0.698); antifungal (0.676);
apoptosis agonist (0.674); antieczematic (0.666)
Antibacterial (0.603); antipruritic (0.582); antileukemic (0.570); immunosuppressant (0.548);
Alzheimer’s disease treatment (0.509)
103 Polarization stimulant (0.604); antineoplastic (0.587)
104 Apoptosis agonist (0.794); antineoplastic (0.794); antiinflammatory (0.747); antiseborrheic (0.616);
antifungal (0.605); neuroprotector (0.601)
Spasmolytic, urinary (0.551); hemostatic (0.542); antioxidant (0.529); antipsoriatic (0.519); antiparasitic
(0.518); ovulation inhibitor (0.513)
105 Antiarthritic (0.923); phobic disorders treatment (0.895); antiasthmatic (0.882); antiallergic (0.872);
cardiovascular analeptic (0.855); hypolipemic (0.790); vasoprotector (0.750); antineurotic (0.706);
rheumatoid arthritis treatment (0.696); autoimmune disorders treatment (0.681); leukopoiesis stimulant
(0.679); antiviral (arbovirus) (0.676); antieczematic (0.656); antipsoriatic (0.654); antinephrotoxic
(0.626); respiratory analeptic (0.592)
106 Vasoprotector (0.897); antieczematic (0.895); antithrombotic (0.891); vasodilator, peripheral (0.861);
antiulcerative (0.844); antiinflammatory (0.834)
Antineoplastic (0.794); antifungal (0.758); immunosuppressant (0.753); apoptosis agonist (0.728);
antiglaucomic (0.722); antiasthmatic (0.712)
Antiallergic (0.697); antipruritic (0.688); fibrinolytic (0.631); hypolipemic (0.628); antiviral (arbovirus)
(0.601); antibacterial (0.597)
*Only activities with Pa > 0.5 are shown
2462 Appl Microbiol Biotechnol (2019) 103:2449–2467
1991). A taxoid, 13-O-acetyl wallifoliol (91), has been isolat-
ed from extracts of the needles of Himalayan Taxus
wallichiana (Velde et al. 1994). Diterpene with the 5/6/6/6/4
ring system called wallifoliol (92) has been isolated from ex-
tracts of the needles of Himalayan Taxus wallichiana (Vander
Velde et al. 1994). Taxumairol Q (93) has been isolated from
the leaves and twigs of Taxus sumatrana. Both compounds
exhibited significant cytotoxicities against both Hepa 59 T/
VGH (human liver carcinoma) and KB (human oral epider-
moid carcinoma) tumor cells (Shen et al. 2002). Anti
Leishmania donovani agent called 10-deacetylbaccatin (94)
and a series of closely related natural organic compounds have
been isolated from the yew tree Taxus sp. (Georgopoulou et al.
2007). Neo-clerodane diterpenoid, chamaedroxide (95), con-
taining an oxetane ring has been found in Teucrium
chamaedrys (Eguren et al. 1982), and the aerial parts of
Teucrium salviastrum contain diterpene teucroxide (96) (De
La Torre et al. 1986).
Highly oxygenated diterpene, trigochinin C (97, structures
shown in Fig. 5 and activity shown in Table 5), was isolated
from Trigonostemon chinensis. The isolated compound
showed significant inhibition against MET tyrosine kinase
activity with at IC50 value of 2 μM (Chen et al. 2010).
Highly oxygenated diterpene, trigonothyrin C (98), was iso-
lated from Trigonostemon chinensis. Obtained diterpene
showed significant inhibition against MET tyrosine kinase
activity with at IC50 value of 2 μM (Chen et al. 2010).
Daphnane diterpenoid, trigothysoid H (99), was isolated from
the methanol extract of the twigs and leaves of Trigonostemon
thyrsoideum (Cheng et al. 2013), the compound demonstrated
potent anti-HIV-1 activity, with EC50 value of 0.001 nM and
TI value of 1618 (Xu and Yue (2014).
Abietane diterpene, triptergulide A (100) containing a
fused 5/6/6/3/6/4 hexacyclic system, was isolated from the
leaves of Tripterygium wilfordii (Ni et al. 2015). Highly func-
tionalized daphnane diterpenoid, namely trigonothyrin A
(101), was found in extract of the stems of Trigonostemon
thyrsoideum (Zhang et al. 2010). A furanoid diterpene of
clerodane type, 12-epi-montanin D (102), was isolated from
the bitter fraction of the areal parts of the Mediterranean tree,
Teucrium montanum (syn. Chamaedrys montana) (Malakov
et al. 1978).
Bisindole alkaloid namely quimbeline (103) has been
found in the root bark of Voacanga chalotiana (Bombardelli
et al. 1975). Sesquiterpene called zizyberanone (104) was iso-
lated from the fruits of a thorny rhamnaceous plant Ziziphus
jujuba (Rhamnaceae) (Guo et al. 2009).
About 300 compounds including 3,3-dimethyl-oxetane
(105) contributing to apple flavor and aroma from different
cultivars Cortland and Empire have been reviewed earlier
(Dimick and Hoskin 1983; Vikram et al. 2004). Hormone
thromboxane A2 (106) has been discovered in the blood plate-
lets (Hamberg et al. 1975; Gryglewski et al. 1978).
Conclusion
In conclusion, we would like to say that this review presents
more than 100 different types of natural metabolites that con-
tain an oxetane ring. Oxetane-containing compounds are pro-
duced by many microorganisms found in marine organisms,
but their highest content was found in plants, especially in the
family of Taxaceae. Oxetane-containing compounds exhibit
various biological activities, but antineoplastic, antiviral, and
antifungal activities are dominant. Many taxol derivatives
show anticancer activity. Our proposed article is the first and
most comprehensive review of the biological activities of rare
natural oxetane-containing compounds.
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